Naglivan

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNaglivan
Drug Alias NameVanadeinePMD-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirbac
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirbac
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A